Amgen Total Liabilities decreased by 9.9% to $999.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 0.1%, from $998.00M to $999.00M. Over 4 years (FY 2020 to FY 2024), Total Liabilities shows an upward trend with a 16.9% CAGR.
A high level of total liabilities relative to equity indicates a more leveraged capital structure and higher financial risk.
The aggregate of all current and non-current debts and obligations owed by the company to external parties. It represent...
Analyzed alongside Total Assets to determine the Debt-to-Asset ratio, which is a standard measure of solvency across all industries.
total_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $562.00M | $554.00M | $876.00M | $1.20B | $1.43B | $1.89B | $1.67B | $1.53B | $1.56B | $1.41B | $1.19B | $1.17B | $1.13B | $998.00M | $1.13B | $984.00M | $1.11B | $999.00M |
| QoQ Change | — | -1.4% | +58.1% | +36.4% | +20.0% | +31.7% | -11.7% | -8.6% | +2.2% | -9.4% | -15.9% | -1.7% | -2.9% | -12.0% | +13.0% | -12.8% | +12.7% | -9.9% |
| YoY Change | — | — | — | — | +155.2% | +240.8% | +90.4% | +27.6% | +8.7% | -25.2% | -28.8% | -23.4% | -27.3% | -29.3% | -5.1% | -15.8% | -2.2% | +0.1% |
We use cookies for analytics. See our Privacy and Cookie Policy.